Latest News on Suche.One

Latest News

TRX bullish soon!

CRYPTOCAP:TRX -@trondao TRON is dedicated to building the infrastructure for a decentralized internet. ? #TRX is currently rejecting a strong demand zone marked in blue. For the bulls to take over and initiate the next upward impulse phase, a break above the last major high marked in green at $0.252 is needed.?

BTC/USD 30-Minute Chart Breakdown!

? ? Chart Pattern Overview: The chart shows a series of trendline breaks forming ascending and descending channels. Multiple higher highs and lower lows were marked with circles. You’ve mapped clear price action structures with zigzag movements indicating market swings. ? Trend Shifts & Trade Zones: Initial bullish structure breaks upward, followed by a sharp reversal. Then, a descending channel forms with retracements offering short-term pullbacks. Entry and exit zones are highlighted with green and red shaded boxes — likely your long/short trades. Each trade setup seems to follow support/resistance and trendline confluence. ? Current Move: The most recent leg shows a strong bearish drop toward a support zone (highlighted with a yellow horizontal line and circle). A bullish reaction candle has formed, possibly signaling a temporary bounce or reversal opportunity. ? Chart Features Used: Support/Resistance levels (yellow, orange, red lines) Trendlines (white) Entry/Exit markings (green/red boxes) Pattern validation (break + retest logic)

Breaking: Alvotech Shares Dips 5% On Earnings Report

Shares of Alvotech (NASDAQ: NASDAQ:ALVO ) saw a noteworthy downtick of 5% amidst earnings report yesterday after market close. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. Financial Performance In 2024, Alvotech's revenue was $491.98 million, an increase of 426.84% compared to the previous year's $93.38 million. Losses were -$231.86 million, -57.98% less than in 2023. Highlights of the Financial Results for 2024 Full Year Cash position and sources of liquidity: As of December 31, 2024, the Company had cash and cash equivalents of $51.4 million. Product Revenue: Product revenue was $273.5 million for the year ended December 31, 2024, compared to $48.7 million for the same period in the prior year. License and Other Revenue: License and other revenue was $216.2 million for the year ended December 31, 2024, compared to $42.7 million for the same period in the prior year. The license and other revenue of $216.2 million was primarily attributable to the achievement of key research and development milestones during 2024: Cost of product revenue: Cost of product revenue was $185.3 million for the year ended December 31, 2024, compared to $160.9 million for the same period in the prior year. Research and development (R&D) expenses: R&D expenses were $171.3 million for the year ended December 31, 2024, compared to $210.8 million for the same period in the prior year. General and administrative (G&A) expenses: G&A expenses were $65.7 million for the year ended December 31, 2024, compared to $76.6 million for the same period in the prior year. Operating profit: Operating profit was $69.6 million for the year ended December 31, 2024, compared to ($354.9) million for the same period in the prior year. Share of net loss of joint venture and loss on sale of interest in joint venture: In June 2024, the Company sold its share in the joint venture for gross proceeds of $18.0 million (less $1.3 million in transaction costs). The sale resulted in a net loss of $3.0 million during the year ended December 31, 2024. Finance income: Finance income was $80.1 million for the year ended December 31, 2024, compared to $4.8 million for the same period in the prior year. Finance costs: Finance costs were $303.2 million for the year ended December 31, 2024, compared to $267.2 million for the same period in the prior year. Loss on extinguishment of financial liabilities: On June 7, 2024, the Company entered into a $965.0 million Senior Loan Facility, maturing in July 2029 that was funded in July 2024. Upon the closing of the Senior Loan Facility, the Company was required to settle its existing debt obligations. Income tax (expense) / benefit: Income tax expense was $14.3 million for the year ended December 31, 2024, compared to a benefit of $99.3 million for the same period in the prior year. Loss for the Year: Reported net loss was $231.9 million, or ($0.87) per share on a basic and diluted basis, for the year ended December 31, 2024, compared to a reported net loss of $551.8 million, or ($2.42) per share on a basic and diluted basis, for the same period in the prior year.

Gold fluctuates at high levels, market trend analysis

After gold broke through 3038, the trend began to strengthen. Then the next step is to change the thinking to low and long and smoothly bullish. The lower side 3038-3035 becomes support. In the evening, it falls back to the 38-35 area. The current market is stagflation near the previous high of 3057. If you are aggressive, you can go short near 3052 and watch for a short-term pullback of a few points. Wait for the top and bottom conversion near 3035 to continue to go long. Strategy: It is recommended to go short at 3051/52, stop loss at 3057, target at 3038-35; the support area below 3035-38 is long, stop loss at 3030, target at 3055-3062;

BITCOING BROKE SUPPORT - GOING TO 82,112

Not a rally yet my friends. It may have looked like a trend would go up and hopefully break 87,500 for our next push upward; however, too much weakness in the market and it broke support so we are headed lower. (My personal perspective)

ETH SMC

I will talk after we reach at posation (we fill all liquidity then go up )

Update Nasdaq 27.03.2025 - Oberkante Daily PDZ erreicht

Gestern Mittag übernahmen die Verkäufer wieder das Ruder, konnten das angesagte Referenz-Low rausnehmen und einen neuen Prio Supply (20'454.50 - 20'486.50) etablieren. Der darauf folgende Abverkauf hat vorerst an der Oberkante des Daily Prio Demand ein Ende gefunden. Ein gestern aufgebauter Minor Demand hat heute bereits zweimal gehalten. Es wäre durchaus vorstellbar, dass wir uns hier an der Oberkante des Daily Prio Demands bereits wieder auf die Long-Seite drehen. Dafür müsste das Referenz-High auf der 20‘147.25 raus genommen werden. Der dann entstehende Prio Demand wäre für mich Long-Einstieg Richtung Prio Supply #1 (20'454.50 - 20'486.50) (blaue Pfeile). Sollte das nicht geschehen, bleibt mein Long-Einstieg der aktuelle Prio Demand #1 (19’725.25 – 19’602.25) (pinke Pfeile). Wichtige Zonen für Einstiege bzw. Ziele: Prio Supply #1: 20'454.50 - 20'486.50 Prio Supply #2: 21’263.75 – 21324.50 Prio Demand #1: 19’725.25 – 19’602.25 Prio Demand #2: 19'184.75 – 19’064.25 Prio Demand #3: 18'728.75 - 18'603.50 Ein ausführliches Journal aller hier vorgestellten Trades, inkl. Link zur jeweiligen Trade-Empfehlung/Analyse, findet Ihr im Link in meiner Bio. Zusammenfassung der Ergebnisse aller der auf Tradinview vorgestellten Trade-Ideen: Net Gain/Loss $4,485.18 Total Commissions $37.82 % Win 58.82% % Loss 41.18% % Break Even 0.00% Average daily gain/loss $373.77 Average winning trade $574.91 Average losing trade -$180.56 Total number of trades 17 Number of winning trades 10 Number of losing trades 7 Number of break even trades 0 Max consecutive wins 4 Max consecutive losses 2 Largest gain $1,673.56 Largest loss -$479.22 Average trade gain/loss $263.83 Average hold time (winning trades) 14:23 Average hold time (lossing trades) 9:19 Max drawdown -$603.94 Average position MFE $727.05 Average position MAE -$183.90

The “One Account for All Blockchains” Particle Network (PARTI), Listed on Bitunix

The adoption of cryptocurrencies is one of the biggest challenges the industry has and there are various reasons for this. According to a survey by Consensys, 40% of the world’s population has interacted with cryptocurrencies by owning them now or at some point in the past. Although this may seem like a satisfactory number, there […]

Liquidity Pressures Surface Despite Stable Capital Ratios, in Basel III Report

The Basel Committee on Banking Supervision has reported that large internationally active banks maintained stable leverage and net stable funding ratios in the first half of 2024, while liquidity coverage ratios declined slightly, raising questions about short-term liquidity management amid evolving regulatory and market conditions. Based on data as of June 30, 2024, the weighted […]